©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 7, 2025; 31(5): 101150
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.101150
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.101150
Rectal neuroendocrine tumors: Can we predict their behavior?
Elisabetta Dell'Unto, Francesco Panzuto, Gianluca Esposito, Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome 00189, Lazio, Italy
Author contributions: Dell’Unto E performed the research and drafted the manuscript; Panzuto F and Esposito G interpreted the data and critically reviewed the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Gianluca Esposito, MD, PhD, Senior Researcher, Department of Medical-Surgical Sciences and Translational Medicine, Sapienza University of Rome, Via G Papanicolau Snc, Rome 00189, Lazio, Italy. gianluca.esposito@uniroma1.it
Received: September 5, 2024
Revised: November 23, 2024
Accepted: December 3, 2024
Published online: February 7, 2025
Processing time: 116 Days and 1.1 Hours
Revised: November 23, 2024
Accepted: December 3, 2024
Published online: February 7, 2025
Processing time: 116 Days and 1.1 Hours
Core Tip
Core Tip: This study proposes the GATIS score, an innovative model designed to predict individualized survival outcomes in patients with rectal neuroendocrine tumors. This model analyzes the relationship between clinicopathological features and patient prognoses. Nevertheless, additional prognostic factors (such as genetic and molecular markers) need to be investigated with further larger multicentric prospective studies.